Predictive Genomics ; Powering the future of population and personalized health

Shantanu will be providing an overview about how predictive genomics is a powerful capability to help predict disease risk and understand drug response in order to improve health outcomes and manage costs. He will be talking about some of the large population scale genotyping efforts implemented on the Applied Biosystems Axiom Microarray platform which have led to personalized health outcomes. This includes the prestigious UK Biobank and the Finngen projects in which genotyping data from customized Axiom microarrays were integrated with biobank data and electronic health records to create a national precision medicine asset of lasting value. Shantanu will also be speaking about how the Axiom microarray platform has been used to drive pharmacogenomics initiatives for clinical research.